Free Trial
NASDAQ:BRBI

BR Biopharma 3/31/2026 Earnings Report

BR Biopharma logo
$14.02 -0.13 (-0.91%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BR Biopharma EPS Results

Actual EPS
$0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BR Biopharma Revenue Results

Actual Revenue
$25.95 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BR Biopharma Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

BR Biopharma Earnings Headlines

No headlines for this company have been tracked by MarketBeat.com
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BR Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BR Biopharma and other key companies, straight to your email.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.

View BR Biopharma Profile